Skip to main content

Table 1 Correlation between the clinical pathologic features and expressions of CUL4A

From: CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to Erlotinib via transcriptional regulation of EGFR

Characteristics

CUL4A

P-valuea

Low or None

High

Gender

Male

21

29

0.732

Female

13

15

Age (years)

53.7 ± 11.6

62.2 ± 15.3

0.197

Pathology

Squamous cell carcinoma

14

16

0.249

Adenocarcinoma

11

18

Adenosquamous carcinoma

9

10

Clinical stage

I

12

5

<0.01b

II

9

10

III

8

17

IV

5

12

  1. aX2 test.
  2. bComparing clinical stages I versus II-IV.